OPHELIA
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.
OPHELIA
Industry:
Health Care Home Health Care Pharmaceutical Therapeutics
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ophelia.com
Total Employee:
1+
Status:
Active
Contact:
(215) 585-2144
Total Funding:
67.7 M USD
Technology used in webpage:
Amazon Google Apps For Business Pound Sterling Amazon S3 CDN Japanese Yen New Relic Fastly Hosted Fastly Load Balancer Amazon Ohio Region Webflow
Similar Organizations
Blade Therapeutics
Blade Therapeutics is a discovery stage drug development company.
DispatchHealth
DispatchHealth is a provider of mobile and virtual healthcare for people of all ages in the comfort of their own homes.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Rubius Therapeutics
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Synapse Medicine
Synapse Medicine offers a medication intelligence platform for healthcare professionals.
Current Employees Featured
Founder
Investors List
General Catalyst
General Catalyst investment in Series B - Ophelia
Four Acres Venture Capital
Four Acres Venture Capital investment in Series B - Ophelia
640 Oxford Ventures
640 Oxford Ventures investment in Series B - Ophelia
Tiger Global Management
Tiger Global Management investment in Series B - Ophelia
Menlo Ventures
Menlo Ventures investment in Series B - Ophelia
Elliot Cohen
Elliot Cohen investment in Series B - Ophelia
Good Friends
Good Friends investment in Series B - Ophelia
Refactor Capital
Refactor Capital investment in Series B - Ophelia
Interplay
Interplay investment in Series B - Ophelia
General Catalyst
General Catalyst investment in Series A - Ophelia
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-22 | Ophelia Appoints Lon Binder as Chief Technology Officer to Increase Investment in Technology |
Official Site Inspections
http://www.ophelia.com Semrush global rank: 598.11 K Semrush visits lastest month: 76.11 K
- Host name: ec2-34-234-52-18.compute-1.amazonaws.com
- IP address: 34.234.52.18
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
